BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 36949445)

  • 1. A multicentre, patient- and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided immunosuppression in kidney transplant recipients in the first year after transplantation: TTVguideIT.
    Haupenthal F; Rahn J; Maggi F; Gelas F; Bourgeois P; Hugo C; Jilma B; Böhmig GA; Herkner H; Wolzt M; Doberer K; Vossen M; Focosi D; Neuwirt H; Banas M; Banas B; Budde K; Viklicky O; Malvezzi P; Rostaing L; Rotmans JI; Bakker SJL; Eller K; Cejka D; Pérez AM; Rodriguez-Arias D; König F; Bond G;
    Trials; 2023 Mar; 24(1):213. PubMed ID: 36949445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Torque teno virus for risk stratification of graft rejection and infection in kidney transplant recipients-A prospective observational trial.
    Doberer K; Schiemann M; Strassl R; Haupenthal F; Dermuth F; Görzer I; Eskandary F; Reindl-Schwaighofer R; Kikić Ž; Puchhammer-Stöckl E; Böhmig GA; Bond G
    Am J Transplant; 2020 Aug; 20(8):2081-2090. PubMed ID: 32034850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Viral load-guided immunosuppression after lung transplantation (VIGILung)-study protocol for a randomized controlled trial.
    Gottlieb J; Reuss A; Mayer K; Weide K; Schade-Brittinger C; Hoyer S; Jaksch P
    Trials; 2021 Jan; 22(1):48. PubMed ID: 33430927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Torque Teno Virus Load Is Associated With Subclinical Alloreactivity in Kidney Transplant Recipients: A Prospective Observational Trial.
    Doberer K; Haupenthal F; Nackenhorst M; Bauernfeind F; Dermuth F; Eigenschink M; Schiemann M; Kläger J; Görzer I; Eskandary F; Reindl-Schwaighofer R; Kikić Ž; Böhmig G; Strassl R; Regele H; Puchhammer-Stöckl E; Bond G
    Transplantation; 2021 Sep; 105(9):2112-2118. PubMed ID: 33587432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Torque Teno Virus for Risk Stratification of Acute Biopsy-Proven Alloreactivity in Kidney Transplant Recipients.
    Strassl R; Doberer K; Rasoul-Rockenschaub S; Herkner H; Görzer I; Kläger JP; Schmidt R; Haslacher H; Schiemann M; Eskandary FA; Kikić Ž; Reindl-Schwaighofer R; Puchhammer-Stöckl E; Böhmig GA; Bond G
    J Infect Dis; 2019 May; 219(12):1934-1939. PubMed ID: 30668796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune monitoring of prevalent kidney transplant recipients using Torque Teno Virus: Protocol for a single-centre prospective cohort study.
    Ho QY; Lai CMD; Liew IT; Oon LLE; Lim KL; Chung SJ; Thangaraju S; Tien SC; Tan CS; Kee T
    BMJ Open; 2023 Sep; 13(9):e076122. PubMed ID: 37730403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Torque Teno Virus Load-Inverse Association With Antibody-Mediated Rejection After Kidney Transplantation.
    Schiemann M; Puchhammer-Stöckl E; Eskandary F; Kohlbeck P; Rasoul-Rockenschaub S; Heilos A; Kozakowski N; Görzer I; Kikić Ž; Herkner H; Böhmig GA; Bond G
    Transplantation; 2017 Feb; 101(2):360-367. PubMed ID: 27525643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of plasma Torque Teno viral load applying a CE-certified PCR for risk stratification of rejection and infection post kidney transplantation.
    Görzer I; Haupenthal F; Maggi F; Gelas F; Kulifaj D; Brossault L; Puchhammer-Stöckl E; Bond G
    J Clin Virol; 2023 Jan; 158():105348. PubMed ID: 36463684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Torque Teno Virus Is Associated With the State of Immune Suppression Early After Liver Transplantation.
    Ruiz P; Martínez-Picola M; Santana M; Muñoz J; Pérez-Del-Pulgar S; Koutsoudakis G; Sastre L; Colmenero J; Crespo G; Navasa M
    Liver Transpl; 2019 Feb; 25(2):302-310. PubMed ID: 30375165
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Torque teno virus loads after kidney transplantation predict allograft rejection but not viral infection.
    van Rijn AL; Wunderink HF; Sidorov IA; de Brouwer CS; Kroes AC; Putter H; de Vries AP; Rotmans JI; Feltkamp MC
    J Clin Virol; 2021 Jul; 140():104871. PubMed ID: 34089977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viruses, friends, and foes: The case of Torque Teno Virus and the net state of immunosuppression.
    Redondo N; Navarro D; Aguado JM; Fernández-Ruiz M
    Transpl Infect Dis; 2022 Apr; 24(2):e13778. PubMed ID: 34933413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial.
    Sommerer C; Suwelack B; Dragun D; Schenker P; Hauser IA; Nashan B; Thaiss F
    Trials; 2016 Feb; 17():92. PubMed ID: 26888217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrated Immunologic Monitoring in Solid Organ Transplantation: The Road Toward Torque Teno Virus-guided Immunosuppression.
    Jaksch P; Görzer I; Puchhammer-Stöckl E; Bond G
    Transplantation; 2022 Oct; 106(10):1940-1951. PubMed ID: 35509090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective cohort study of Torque Teno Virus (TTV) viral load kinetics and the association with graft rejection in renal transplant patients.
    Reyes NS; Laham G; Boccia N; García G; Jara R; Hermida E; Ricarte C; Diaz C; Soler Pujol G; Poletta FA; Echavarria M
    J Clin Virol; 2023 Aug; 165():105501. PubMed ID: 37379781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking, Alcohol Intake and Torque Teno Virus in Stable Kidney Transplant Recipients.
    Doorenbos CSE; Jonker J; Hao J; Gore EJ; Kremer D; Knobbe TJ; de Joode AAE; Sanders JSF; Thaunat O; Niesters HGM; Van Leer-Buter CC; Bakker SJL
    Viruses; 2023 Dec; 15(12):. PubMed ID: 38140628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. No correlation between Torque Teno virus viral load and BK virus replication after kidney transplantation.
    Handala L; Descamps V; Morel V; Castelain S; François C; Duverlie G; Helle F; Brochot E
    J Clin Virol; 2019 Jul; 116():4-6. PubMed ID: 30986626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of Torque Teno Virus-DNA Plasma Load Predict Rejection in Lung Transplant Recipients.
    Frye BC; Bierbaum S; Falcone V; Köhler TC; Gasplmayr M; Hettich I; Dürk T; Idzko M; Zissel G; Hengel H; Müller-Quernheim J
    Transplantation; 2019 Apr; 103(4):815-822. PubMed ID: 30234787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clazakizumab in late antibody-mediated rejection: study protocol of a randomized controlled pilot trial.
    Eskandary F; Dürr M; Budde K; Doberer K; Reindl-Schwaighofer R; Waiser J; Wahrmann M; Regele H; Spittler A; Lachmann N; Firbas C; Mühlbacher J; Bond G; Halloran PF; Chong E; Jilma B; Böhmig GA
    Trials; 2019 Jan; 20(1):37. PubMed ID: 30635033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Density Lipoprotein Particles and Torque Teno Virus in Stable Outpatient Kidney Transplant Recipients.
    Jonker J; Doorenbos CSE; Kremer D; Gore EJ; Niesters HGM; van Leer-Buter C; Bourgeois P; Connelly MA; Dullaart RPF; Berger SP; Sanders JF; Bakker SJL
    Viruses; 2024 Jan; 16(1):. PubMed ID: 38257843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Torque teno virus load as marker of rejection and infection in solid organ transplantation - A systematic review and meta-analysis.
    van Rijn AL; Roos R; Dekker FW; Rotmans JI; Feltkamp M
    Rev Med Virol; 2023 Jan; 33(1):e2393. PubMed ID: 36056751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.